A multicenter retrospective analysis of patients with salivary gland carcinoma treated with postoperative radiotherapy alone or chemoradiotherapy

Rodney Cheng-En Hsieh,Yung-Chih Chou,Chia-Yen Hung,Li-Yu Lee,Bhanu Prasad Venkatesulu,Shiang-Fu Huang,Chun-Ta Liao,Nai-Ming Cheng,Hung-Ming Wang,Chiao-En Wu,Chung-Jan Kang,Miao-Fen Chen,Yu-Fan Cheng,Kun-Yun Yeh,Cheng-Hsu Wang,Wen-Chi Chou,Chien-Yu Lin
DOI: https://doi.org/10.1016/j.radonc.2023.109891
IF: 6.901
2023-09-02
Radiotherapy and Oncology
Abstract:Background The aim of this study was to interrogate if the use of postoperative chemoradiotherapy (POCRT) correlated with superior oncological outcomes for certain subgroups of patients with high-risk salivary gland carcinoma (SGC), compared with postoperative radiotherapy (PORT) alone. Methods This multicenter retrospective study included 411 patients with surgically resected SGC who underwent PORT ( n = 263) or POCRT ( n = 148) between 2000 and 2015. Possible correlations of clinical parameters with outcomes were examined using the Kaplan-Meier analysis and Cox proportional-hazards regression model. Results The median follow-up of survivors is 10.9 years. For the entire cohort, adding concurrent chemotherapy to PORT was not associated with OS, PFS, or LRC improvement. However, patients with nodal metastasis who underwent POCRT had significantly higher 10-year OS (46.2% vs. 18.2%, P=0.009) and PFS (38.7% vs. 10.0%, P=0.009) rates than those treated with PORT alone. The presence of postoperative macroscopic residual tumor (R2 resection) was identified as an independent prognosticator for inferior OS (P=0.032), PFS (P=0.001), and LRC (P=0.007). Importantly, POCRT significantly correlated with higher 10-year LRC rates in patients with R2 resection (74.2% vs. 40.7%, P=0.032) or adenoid cystic carcinoma (AdCC, 97.6% vs. 83.6%, P=0.036). On multivariate analyses, the use of POCRT significantly predicted superior OS (P=0.037) and PFS (P=0.013) for node-positive patients and LRC for patients with R2 resection (P=0.041) or AdCC (P=0.005). Conclusions For surgically resected SGC, POCRT was associated with improved long-term OS and PFS for patients with nodal metastasis and superior LRC for patients with R2 resection or AdCC.
oncology,radiology, nuclear medicine & medical imaging
What problem does this paper attempt to address?